| James G Schwendig, MD | |
|
9888 Genesee Ave, Lj-601, La Jolla, CA 92037-1205 | |
| (858) 626-6350 | |
| (858) 626-6354 |
| Full Name | James G Schwendig |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 34 Years |
| Location | 9888 Genesee Ave, La Jolla, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043307184 | NPI | - | NPPES |
| 00G731051 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0127X | Surgery - Trauma Surgery | G73105 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Scripps Memorial Hospital La Jolla | La jolla, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scripps Health | 9234033853 | 1362 |
News Archive
Gamma-linolenic acid (GLA), a substance in evening primrose oil and several other plant oils used in herbal medicine, inhibits action of Her-2/neu, a cancer gene that is responsible for almost 30 percent of all breast cancers, Northwestern University researchers report.
A new biosensor, applied to the human skin like a temporary tattoo, can alert marathoners, competitive bikers and other "extreme" athletes that they're about to "bonk," or "hit the wall," scientists are reporting. The study, in ACS' journal Analytical Chemistry, describes the first human tests of the sensor, which also could help soldiers and others who engage in intense exercise - and their trainers - monitor stamina and fitness.
Reported cases, by Dr. Jan Lidström, which involve 20 patients with soft tissue defects in the foot with up to four years follow-up together with a biomechanical study, by Dr. Eric Giza, confirm the positive clinical outcome orthopedic foot surgeons have experienced with Artelon Tissue Reinforcement (ATR).
ZymoGenetics, Inc. today announced the initiation of the second part of a Phase 2 clinical trial with PEG-Interferon lambda (IL-29) and ribavirin in treatment-naïve patients with chronic hepatitis C virus (HCV) infection. ZymoGenetics is developing the investigational compound PEG-Interferon lambda in collaboration with Bristol-Myers Squibb Company.
Passionate medical and allied health professional students are taking their skills to the community in a life-saving initiative they are leading in Leicester City Centre.
› Verified 6 days ago
| Entity Name | Scripps Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881636108 PECOS PAC ID: 9234033853 Enrollment ID: O20031124000822 |
News Archive
Gamma-linolenic acid (GLA), a substance in evening primrose oil and several other plant oils used in herbal medicine, inhibits action of Her-2/neu, a cancer gene that is responsible for almost 30 percent of all breast cancers, Northwestern University researchers report.
A new biosensor, applied to the human skin like a temporary tattoo, can alert marathoners, competitive bikers and other "extreme" athletes that they're about to "bonk," or "hit the wall," scientists are reporting. The study, in ACS' journal Analytical Chemistry, describes the first human tests of the sensor, which also could help soldiers and others who engage in intense exercise - and their trainers - monitor stamina and fitness.
Reported cases, by Dr. Jan Lidström, which involve 20 patients with soft tissue defects in the foot with up to four years follow-up together with a biomechanical study, by Dr. Eric Giza, confirm the positive clinical outcome orthopedic foot surgeons have experienced with Artelon Tissue Reinforcement (ATR).
ZymoGenetics, Inc. today announced the initiation of the second part of a Phase 2 clinical trial with PEG-Interferon lambda (IL-29) and ribavirin in treatment-naïve patients with chronic hepatitis C virus (HCV) infection. ZymoGenetics is developing the investigational compound PEG-Interferon lambda in collaboration with Bristol-Myers Squibb Company.
Passionate medical and allied health professional students are taking their skills to the community in a life-saving initiative they are leading in Leicester City Centre.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James G Schwendig, MD 9888 Genesee Ave, Lj-601, La Jolla, CA 92037-1205 Ph: (858) 626-6350 | James G Schwendig, MD 9888 Genesee Ave, Lj-601, La Jolla, CA 92037-1205 Ph: (858) 626-6350 |
News Archive
Gamma-linolenic acid (GLA), a substance in evening primrose oil and several other plant oils used in herbal medicine, inhibits action of Her-2/neu, a cancer gene that is responsible for almost 30 percent of all breast cancers, Northwestern University researchers report.
A new biosensor, applied to the human skin like a temporary tattoo, can alert marathoners, competitive bikers and other "extreme" athletes that they're about to "bonk," or "hit the wall," scientists are reporting. The study, in ACS' journal Analytical Chemistry, describes the first human tests of the sensor, which also could help soldiers and others who engage in intense exercise - and their trainers - monitor stamina and fitness.
Reported cases, by Dr. Jan Lidström, which involve 20 patients with soft tissue defects in the foot with up to four years follow-up together with a biomechanical study, by Dr. Eric Giza, confirm the positive clinical outcome orthopedic foot surgeons have experienced with Artelon Tissue Reinforcement (ATR).
ZymoGenetics, Inc. today announced the initiation of the second part of a Phase 2 clinical trial with PEG-Interferon lambda (IL-29) and ribavirin in treatment-naïve patients with chronic hepatitis C virus (HCV) infection. ZymoGenetics is developing the investigational compound PEG-Interferon lambda in collaboration with Bristol-Myers Squibb Company.
Passionate medical and allied health professional students are taking their skills to the community in a life-saving initiative they are leading in Leicester City Centre.
› Verified 6 days ago
Dr. Howard Takiff, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 760 La Canada St, La Jolla, CA 92037 Phone: 949-981-4018 | |
Mahmoud Malas, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9434 Medical Center Dr Fl 1, La Jolla, CA 92037 Phone: 619-543-6980 Fax: 858-657-5033 | |
Cheryl Lorraine Olson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9850 Genesee Ave, Suite 660, La Jolla, CA 92037 Phone: 858-452-5054 Fax: 858-452-5097 | |
Angeles Baquerizo, Surgery Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd # 200n, La Jolla, CA 92037 Phone: 858-544-4310 | |
Dr. David Alexander Frankel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-8988 | |
Ayemoethu Ma, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd # Ms 213, La Jolla, CA 92037 Phone: 858-554-8984 Fax: 858-554-5055 |